RxDoctor Payments Data

Michael Kain, MD

Orthopaedic Surgery · Boston, MANPI 1104092055

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $111,650 of the $171,319 with a category attached, or 65.2%. Smith+Nephew accounts for 88.7% of it on its own, with 12 other manufacturers making up the rest. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$171,319in general payments, 2019–2025

Across 226 payments — averaging $758.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$152K
  • Arthrex$8K
  • Kairos Surgical Inc$4K
  • Elite Orthopedics, LLC$3K
  • Stryker$2K
  • Zimmer Biomet$475
  • plus $991 from 7 others
$75in research payments, 2019–2025

Across 1 payment — averaging $74.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aesculap Implant Systems, LLC$75

What the payments were for

  • Consulting fees$24,52514%
  • Speaking & faculty fees$111,65065%
  • Travel & lodging$17,59510%
  • Food & beverage$9,2625%
  • Education$8,2885%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$171,319 in reported general payments places this provider in the 95th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$65,773
Medicare patients
86
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →